Structural insights into terminal arabinosylation of mycobacterial cell wall arabinan

The global challenge of tuberculosis, caused by Mycobacterium tuberculosis (Mtb) , is compounded by the emergence of drug-resistant strains. A critical factor in Mtb ’s pathogenicity is its intricate cell envelope, which acts as a formidable barrier against immune defences and pharmacological interv...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 16; no. 1; pp. 3973 - 16
Main Authors Liu, Yaqi, Brown, Chelsea M., Erramilli, Satchal, Su, Yi-Chia, Guu, Shih-Yun, Tseng, Po-Sen, Wang, Yu-Jen, Duong, Nam Ha, Tokarz, Piotr, Kloss, Brian, Han, Cheng-Ruei, Chen, Hung-Yu, Rodrigues, José, Khoo, Kay-Hooi, Archer, Margarida, Kossiakoff, Anthony A., Lowary, Todd L., Stansfeld, Phillip J., Nygaard, Rie, Mancia, Filippo
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 29.04.2025
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The global challenge of tuberculosis, caused by Mycobacterium tuberculosis (Mtb) , is compounded by the emergence of drug-resistant strains. A critical factor in Mtb ’s pathogenicity is its intricate cell envelope, which acts as a formidable barrier against immune defences and pharmacological interventions. Central to this envelope are arabinogalactan (AG) and lipoarabinomannan (LAM), two complex polysaccharides containing arabinan domains essential for maintaining cell wall structure and function. The arabinofuranosyltransferase AftB plays a pivotal role in the biosynthesis of these arabinan domains by catalyzing the addition of β-(1 → 2)-linked terminal arabinofuranose residues. Here, we present the cryo-EM structures of Mycobacterium chubuense AftB in both its apo form and bound to a donor substrate analog, resolved at 2.9 Å and 3.4 Å resolution, respectively. These structures reveal that AftB has a GT-C fold, with a transmembrane (TM) domain comprised of eleven TM helices and a periplasmic cap domain. AftB has a distinctive irregular, tube-shaped cavity that connects two proposed substrate binding sites. Through an integrated approach combining structural analysis, biochemical assays, and molecular dynamics simulations, we delineate the molecular basis of AftB’s reaction mechanism and propose a model for its catalytic function. Here, the authors present cryoEM structures of AftB, a key mycobacterial enzyme that adds terminal arabinose residues to the cell wall. In concert with functional assays and MD simulations, mechanistic insights are presented.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-025-58196-5